Qin Shan-Yu, Zhou You, Li Ping, Jiang Hai-Xing
Department of Gastroenterology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
Minerva Foundation Institute for Medical Research, Helsinki, Finland.
PLoS One. 2014 Sep 26;9(9):e108762. doi: 10.1371/journal.pone.0108762. eCollection 2014.
The diagnostic efficiency of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) cytology varies widely depending on the treatment method of the specimens. The present study aimed to evaluate the diagnostic efficacy of cell block (CB) immunohistochemistry, smear cytology (SC), and liquid-based cytology (LBC) in patients with pancreatic lesions without consulting an on-site cytopathologist.
This study prospectively enrolled 72 patients with pancreatic lesions. The EUS-FNA specimens were examined by SC, LBC, and CB immunohistochemistry. The diagnostic efficacy of the 3 methods was then compared. Patients' final diagnosis was confirmed by surgical resection specimens, diagnostic imaging, and clinical follow-up.
Our results included 60 malignant and 12 benign pancreatic lesions. The diagnostic sensitivity (90%), negative predictive value (66.7%), and accuracy (91.7%) of CB immunohistochemistry were significantly higher than those of SC (70.0%, 30.0%, and 75.0%, respectively) and LBC (73.3%, 31.6%, and 77.8%, respectively) (all P<0.05). The combination of CB and SC, or CB and LBC, did not significantly increase the efficacy compared to CB immunohistochemistry alone.
Our findings suggest that in the absence of an on-site cytopathologist, CB immunohistochemistry on EUS-FNA specimens offers a higher diagnostic efficacy in patients with pancreatic lesions than does SC and LBC.
内镜超声引导下细针穿刺抽吸(EUS-FNA)细胞学检查的诊断效率因标本处理方法不同而有很大差异。本研究旨在评估在不咨询现场细胞病理学家的情况下,细胞块(CB)免疫组织化学、涂片细胞学(SC)和液基细胞学(LBC)对胰腺病变患者的诊断效能。
本研究前瞻性纳入72例胰腺病变患者。EUS-FNA标本采用SC、LBC和CB免疫组织化学进行检查。然后比较这三种方法的诊断效能。患者的最终诊断通过手术切除标本、诊断性影像学检查和临床随访得以证实。
我们的研究结果包括60例恶性胰腺病变和12例良性胰腺病变。CB免疫组织化学的诊断敏感性(90%)、阴性预测值(66.7%)和准确性(91.7%)显著高于SC(分别为70.0%、30.0%和75.0%)和LBC(分别为73.3%、31.6%和77.8%)(所有P<0.05)。与单独使用CB免疫组织化学相比,CB与SC或CB与LBC联合使用并未显著提高诊断效能。
我们的研究结果表明,在没有现场细胞病理学家的情况下,EUS-FNA标本的CB免疫组织化学对胰腺病变患者的诊断效能高于SC和LBC。